![Hagit Ashus](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hagit Ashus
Corporate Officer/Principal bij Quark Pharmaceuticals, Inc.
Actieve functies van Hagit Ashus
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Corporate Officer/Principal | 27-09-2010 | - |
Loopbaan van Hagit Ashus
Opleiding van Hagit Ashus
Bar-Ilan University | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 2 |
Israël | 2 |
Operationeel
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Beurs
- Insiders
- Hagit Ashus
- Ervaring